Fabrice Harari leads Steba Biotech’s operations and represents Shareholders interest. As the CEO of Steba Biotech, Fabrice Harari was responsible for running all facets of the business. He has a proven executive management track record and over 20 years of experience driving growth in the pharma industry. Prior to joining Steba Biotech, Fabrice was for 7 years the Chief Executive Officer of Ifrah Finance SA, the holding company of Negma Laboratories in France. He redefined the priorities, restructured the company, licensed in new products to extend the portfolio and sold nonstrategic assets. He prepared the company for an optimum M&A transaction that occurred in 2007, spinning off Steba Biotech. From 1999 to 2001 he was the CEO of Hazal Finance and he coordinated the sale of an end of phase II Statin product to Novartis. Fabrice Harari is also in charge of investing and managing the family funds for over 17 years. Investments are diversified mainly in private equity, financing, and real estates. He graduated from Paris Dauphine in Business and Finance.